Why the study?
Is plasma adiponectin level associated with the severity of coronary artery disease in patients undergoing coronary angiography?
Is plasma adiponectin level associated with the severity of coronary artery disease in patients undergoing coronary angiography?
Plasma adiponectin levels are inversely correlated with the severity of coronary artery stenosis, suggesting its potential utility as a biomarker for CAD severity.
Adiponectin was associated with CAD severity; hypothesis-generating for biomarker utility, should not yet change practice.
Adipocyte-derived adiponectin has an antiatherosclerotic effect that acts independently of its antidiabetic effect. Plasma adiponectin levels are generally low in subjects with coronary artery disease. In this study, the relationship between the plasma adiponectin level and the severity of coronary artery disease, as assessed using the Gensini score, an index for the severity of coronary artery stenosis, was investigated. The subjects of the study were 104 patients (72 men and 32 women; BMI, 23.5 +/- 3.3 kg/m(2); age, 63.6 +/- 10.1 years) admitted to Tokyo University Hospital for coronary angiography. Plasma adiponectin levels were inversely correlated with the insulin resistance index HOMA-IR (P = 0.0127). The plasma adiponectin level was significantly associated with the Gensini score (P = 0.0332). After adjustment for conventional risk factors for cardiovascular diseases, the plasma adiponectin level tended to be inversely correlated with the Gensini score (P = 0.087). The measurement of plasma adiponectin levels may be useful for predicting the severity of coronary artery stenosis.
No takes yet. Share an insight, caveat, or question.
Hara et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: